Log in to save to my catalogue

Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol...

Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7f0f68745bd744c9a1f5e7cee447adcd

Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial

About this item

Full title

Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial

Publisher

England: BioMed Central Ltd

Journal title

Current controlled trials in cardiovascular medicine, 2020-04, Vol.21 (1), p.307-9, Article 307

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Interstitial lung diseases in children (chILD) are rare and consist of many different entities that affect the parenchyma of the lungs, leading to a chronic lung disease. The natural course of many of these diseases is connected with a high morbidity and significant mortality. Symptomatic treatment consists of oxygen supplementation, adequate nutri...

Alternative Titles

Full title

Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7f0f68745bd744c9a1f5e7cee447adcd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7f0f68745bd744c9a1f5e7cee447adcd

Other Identifiers

ISSN

1745-6215

E-ISSN

1745-6215

DOI

10.1186/s13063-020-4188-4

How to access this item